Efficacy and Safety of Eplivanserin Treatment for Sleep Maintenance Insomnia Followed by Optional Extension up to 1 Year

NCT00253903 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1155

Enrollment

INDUSTRY

Sponsor class

Conditions

Sleep Initiation and Maintenance Disorders
Insomnia

Interventions

DRUG: eplivanserin (SR46349)
DRUG: placebo

Sponsor

Sanofi